Literature DB >> 25581130

Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy.

Stephen C Wilson1, Jeremy L Baryza, Aimee J Reynolds, Keith Bowman, Mark E Keegan, Stephany M Standley, Noah P Gardner, Parul Parmar, Vahide Ozlem Agir, Sunita Yadav, Adnan Zunic, Chandra Vargeese, Cameron C Lee, Srinivasan Rajan.   

Abstract

Small interfering RNA (siRNA) is a novel therapeutic modality that benefits from nanoparticle mediated delivery. The most clinically advanced siRNA-containing nanoparticles are polymer-coated supramolecular assemblies of siRNA and lipids (lipid nanoparticles or LNPs), which protect the siRNA from nucleases, modulate pharmacokinetics of the siRNA, and enable selective delivery of siRNA to target cells. Understanding the mechanisms of assembly and delivery of such systems is complicated by the complexity of the dynamic supramolecular assembly as well as by its subsequent interactions with the biological milieu. We have developed an ex vivo method that provides insight into how LNPs behave when contacted with biological fluids. Pulsed gradient spin echo (PGSE) NMR was used to directly measure the kinetics of poly(ethylene) glycol (PEG) shedding from siRNA encapsulated LNPs in rat serum. The method represents a molecularly specific, real-time, quantitative, and label-free way to monitor the behavior of a nanoparticle surface coating. We believe that this method has broad implications in gaining mechanistic insights into how nanoparticle-based drug delivery vehicles behave in biofluids and is versatile enough to be applied to a diversity of systems.

Entities:  

Keywords:  LNP; PEG shedding; PEG-lipid; PGSE NMR; lipid nanoparticle; liposome; micelle; nanoparticle; siRNA

Mesh:

Substances:

Year:  2015        PMID: 25581130     DOI: 10.1021/mp500400k

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  5 in total

1.  Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.

Authors:  Shanthi Ganesh; Martin L Koser; Wendy A Cyr; Girish R Chopda; Junyan Tao; Xue Shui; Bo Ying; Dongyu Chen; Purva Pandya; Edmond Chipumuro; Zakir Siddiquee; Kevin Craig; Chengjung Lai; Henryk Dudek; Satdarshan P Monga; Weimin Wang; Bob D Brown; Marc T Abrams
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

2.  On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles.

Authors:  Sean A Dilliard; Qiang Cheng; Daniel J Siegwart
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-28       Impact factor: 12.779

3.  Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).

Authors:  Ester Álvarez-Benedicto; Lukas Farbiak; Martha Márquez Ramírez; Xu Wang; Lindsay T Johnson; Osamah Mian; Erick D Guerrero; Daniel J Siegwart
Journal:  Biomater Sci       Date:  2022-01-18       Impact factor: 7.590

Review 4.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881

Review 5.  Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme.

Authors:  Kirsten Rasmussen; Hubert Rauscher; Agnieszka Mech; Juan Riego Sintes; Douglas Gilliland; Mar González; Peter Kearns; Kenneth Moss; Maaike Visser; Monique Groenewold; Eric A J Bleeker
Journal:  Regul Toxicol Pharmacol       Date:  2017-10-23       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.